THE ROLE OF BIOCHEMICAL MARKERS IN SCREENING OF CERVICAL EPITHELIAL PATHOLOGY WITH DETERMINATION OF P16INK4A PROTEIN EXPRESSION
Dilfuzahon Zakirjanovna Mamarasulova , Professor At The Department Of Medical Oncology At The Andijan State Medical Institute, Andijan, UzbekistanAbstract
This article describes the role of biochemical markers in the pathology of the cervical epithelium. In research 10716 women aged 25-65 years were examined (mean age 43.28±3.82 years). And in the course of the study, it was found that the expression of the P16INK4A protein by cervical epithelial cells increases the risk of epithelial metaplasia of any degree by 8.86 times, high-grade epithelial metaplasia - by 692 times, RMS by 48 times.
Keywords
Cervical cancer, early diagnosis, biochemical markers
References
Huh WK, Williams E, Huang J, Bramley T, Poulios N. Cost effectiveness of human papillomavirus-16/18 genotyping in cervical cancer screening. Appl. Health Econ. Health Policy. 2015; 13:95–107 IARC. Cervix cancer screening, Vol 10 (IARC, Lyon, 2005).
Ikenberg H, Bergeron C, Schmidt D, Griesser H, Alameda F, Angeloni C, et al. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study. J. Natl Cancer Inst. 2013;105:1550–1557.
Insinga RP, Glass AG, Rush BB. Diagnoses and outcomes in cervical cancer screening: a population-based study. Am. J. Obstet. Gynecol. 2004;191:105–113.
Jeong DH, Youm MY, Kim YN, Lee KB, Sung MS, Yoon HK, Kim KT. Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics. Int J Gynecol Cancer. 2006;16(3):1234–1240.
Kang S, Kim J, Kim HB, Shim JW, Nam E, Kim SH, Ahn HJ, Choi YP, Ding B, Song K, Cho NH. Methylation of p16INK4a is a non-rare event in cervical intraepithelial neoplasia. Diagn Mol Pathol. 2006;15(2):74–82.
Luttmer R, De Strooper LM, Berkhof J, Snijders PJ, Dijkstra MG, Uijterwaal MH, et al. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study) Int. J. Cancer. 2016;138:992–1002.
Ma YT, Collins SI, Young LS, Murray PG, Woodman CB. Smoking initiation is followed by the early acquisition of epigenetic change in cervical epithelium: a longitudinal study. Br J Cancer. 2011;104(9):1500–1504.
Mabuchi S, Isohashi F, Yokoi T, Takemura M, Yoshino K, et al. A phase II study of postoperative concurrent carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy followed by consolidation chemotherapy in surgically treated cervical cancer patients with positive pelvic lymph nodes. Gynecol Oncol. 2016;141:240–246. doi: 10.1016/j.ygyno.2016.02.011.
Spathis A, Aga E, Alepaki M, Chranioti A, Meristoudis C, Panayiotides I, Kassanos D, Karakitsos P. Promoter methylation of p16(INK4A), hMLH1, and MGMT in liquid-based cervical cytology samples compared with clinicopathological findings and HPV presence. Infect Dis Obstet Gynecol. 2011;2011:927861.
Yang HJ, Liu VW, Wang Y, Chan KY, Tsang PC, Khoo US, Cheung AN, Ngan HY. Detection of hypermethylated genes in tumor and plasma of cervical cancer patients. Gynecol Oncol. 2004;93(2):435–440.
Yang HJ, Liu VW, Wang Y, Tsang PC, Ngan HY. Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data. BMC Cancer. 2006;6:212
Zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92(9):690–698.
Article Statistics
Copyright License
Copyright (c) 2024 Dilfuzahon Zakirjanovna Mamarasulova
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.